Search Results for: Achaogen Announces Positive Results in
Articles
December 20, 2016
Achaogen Announces Positive Results in Phase III Trials December 20, 2016
Achaogen, Inc. recently announced its lead product candidate, plazomicin, met the objective of non-inferiority compared to meropenem for the US...
